Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 149, Issue 1, 2010, Pages 31-36

  Altieri, Paola ^a   Gambineri, Alessandra ^a   Prontera, Olga ^a   Cionci, Gianluca ^a   Franchina, Michele ^a   Pasquali, Renato ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Gestational diabetes; Polycystic ovary syndrome; Pregnancy outcome

Indexed keywords

ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CARDIOVASCULAR MALFORMATION; CHOLESTASIS; CONCEPTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HEALTH SURVEY; HELLP SYNDROME; HUMAN; HYPERANDROGENISM; ITALY; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICAL RECORD REVIEW; MENSTRUAL CYCLE; MOUTH MALFORMATION; OVARY POLYCYSTIC DISEASE; PARITY; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; STILLBIRTH; TELEPHONE; WEIGHT GAIN;

EID: 76049095515     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.11.010     Document Type: Article

References (30)

1. Pasquali R., and Gambineri A. Mechanisms and treatment of obesity in polycystic ovary syndrome. In: Dunaif A., Chang R.J., Franks S., and Legro S. (Eds). Polycystic ovary syndrome. Current controversies, from the ovary to the pancreas (2008), Humana Press, Totowa, NJ 217-240
2. Legro R.S., Castracane V.D., and Kauffman R.P. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 59 (2004) 141-154
3. Pasquali R., Gambineri A., Anconetani B., et al. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the long-term effect of oestrogen-progestagen treatment. Clin Endocrinol (Oxford) 50 (1999) 517-527
4. Gambineri A., Pelusi C., Manicardi E., et al. Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome. Phenotype and associated factors. Diabetes 53 (2004) 2353-2358
5. Sivan E., and Boden G. Free fatty acids, insulin resistance, and pregnancy. Curr Diab Rep 3 (2003) 319-322
6. Jensen R.B., Chellakooty M., Vielwerth S., et al. Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life: does insulin-like growth factor-I play a role?. Horm Res 60 Suppl. 3 (2003) 136-148
7. Mikola M., Hiilesmaa V., Halttunen M., Suhonen L., and Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 16 (2001) 226-229
8. Radon P.A., McMahon M.J., and Meyer W.R. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 94 (1999) 194-197
9. Urman B., Sarac E., Dogan L., and Gurgan T. Pregnancy in infertile PCOD patients. Complications and outcome. J Reprod Med 42 (1997) 501-505
10. Lo J.C., Feigenbaum S.L., Escobar G.J., Yang J., Crites Y.M., and Ferrara A. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care 29 (2006) 1915-1917
11. Sir-Petermann T., Echiburú B., Maliqueo M., et al. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Hum Reprod 22 (2007) 1830-1836
12. Boomsma C.M., Eijkemans M.J.C., Hughes E.G., Visser G.H.A., Fauser B.C.J.M., and Macklon N.S. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12 (2006) 673-683
13. Siassakos D., and Wardle P. Polycystic ovary syndrome and pregnancy outcome: red herring or red flag?. BJOG 114 (2007) 922-932
14. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 26 (2003) S103-S105
15. Ferriman D., and Gallwey J.D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21 (1961) 1440-1447
16. The Rotterdam ESHRE/ASRM-Sponsored, PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
17. Getahun D., Nath C., Ananth C.V., Chavez M.R., and Smulian J.C. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol 198 (2008) 525.e1-525.e5
18. Di Cianni G., Volpe L., Lencioni C., et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract 62 (2003) 131-137
19. Wallis A.B., Saftlas A.F., Hsia J., and Atrash H.K. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 21 (2008) 521-526
20. Institute of Medicine, and National Academy of Sciences. Nutrition during pregnancy (1990), National Academy Press, Washington, DC
21. Zawadzki J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: toward a rational approach. In: Dunaif A., Givens J.R., and Haseline F. (Eds). Polycystic ovary syndrome (1992), Blackwell Scientific, Boston 377-384
22. Broekmans F.J., Knauff E.A., Valkenburg O., Laven J.S., Eijkemans M.J., and Fauser B.C. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 113 (2006) 1210-1217
23. Koivunen R., Pouta A., Franks S., et al. Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod 23 (2008) 2134-2139
24. Pasquali R., Patton L., and Gambineri A. Obesity and infertility. Curr Opin Endocrinol Diabetes Obes 14 (2007) 482-487
25. Vulpoi C., Lecomte C., Guilloteau D., and Lecomte P. Ageing and reproduction: is polycystic ovary syndrome an exception?. Ann Endocrinol (Paris) 68 (2007) 45-50
26. Haakova L., Cibula D., Rezabek K., Hill M., Fanta M., and Zivny J. Pregnancy outcome in women with PCOS and in controls matched by age and weight. Hum Reprod 18 (2003) 1438-1441
27. Vollenhoven B., Clark S., Kovacs G., Burger H., and Healy D. Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins. Aust N Z J Obstet Gynaecol 40 (2000) 54-58
28. Kabiru W., and Raynor B.D. Obstetric outcomes associated with increase in BMI category during pregnancy. Am J Obstet Gynecol 191 (2004) 928-932
29. Pasquali R., Patton L., Pocognoli P., Cognigni G.E., and Gambineri A. 17-Hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome. J Clin Endocrinol Metab 92 (2007) 4208-4217
30. Sadrzadeh S., Klip W.A., Broekmans F.J., et al. Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve in a retrospective cohort. Hum Reprod 18 (2003) 2225-2230